Titan Biotech Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013
For the nine months, the company reported total income from operations of INR 280.124 million compared to INR 196.151 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 15.315 million compared to INR 15.318 million a year ago. Profit before tax was INR 17.229 million compared to INR 14.792 million a year ago. Net profit was INR 11.373 million compared to INR 9.911 million a year ago. Basic and diluted earnings per share before and after extraordinary items were INR 1.80 compared to INR 1.41 a year ago.